Glancy Prongay & Murray Will Lead Omnicell Stock Drop Suit
Glancy Prongay & Murray LLP will lead the proposed class in a shareholder's suit over medication automator Omnicell's stock drop following a short-seller's critical report on the company, a California federal...To view the full article, register now.
Already a subscriber? Click here to view full article